According to the latest research analysis,the global market for Hematology and Coagulation should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Hematology and Coagulation market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Hematology and Coagulation market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Hematology segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Children has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Hematology and Coagulation include Abbott Diagnostics, Beckman Coulter, Inc., CellaVision AB, Diagnostica Stago, S.A.S., DIAGON Kft. Hungary, HemoCue, Horiba Medical, Medica Corporation and Microvisk Technologies, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Hematology and Coagulation.
Data-Driven Insights: Highlights from Our Report
(1) Global Hematology and Coagulation market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Hematology and Coagulation market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Hematology and Coagulation market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Hematology and Coagulation segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Hematology and Coagulation segment by type and by application and regional segment by type and by application.
(6) Hematology and Coagulation industry supply chain, upstream, midstream and downstream analysis.
Breaking Down Market Segments by Region: A Deep Dive Analysis
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Understanding Market Segments by Type: A Comparative Analysis
Hematology
Coagulation
Market Segmentation by Application: Dividing Key Markets and Identifying Opportunities
Children
Adult
Understanding Market Segments by Key Players: Insights and Opportunities
Abbott Diagnostics
Beckman Coulter, Inc.
CellaVision AB
Diagnostica Stago, S.A.S.
DIAGON Kft. Hungary
HemoCue
Horiba Medical
Medica Corporation
Microvisk Technologies
Mindray
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Werfen (Instrumentation Laboratory, Accriva Diagnostics)
West Medica
1 Market Overview
1.1 Product Overview and Scope of Hematology and Coagulation
1.2 Global Hematology and Coagulation Market Size and Forecast
1.3 China Hematology and Coagulation Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Hematology and Coagulation Share in Global Market, 2018-2029
1.4.2 Hematology and Coagulation Market Size: China VS Global, 2018-2029
1.5 Hematology and Coagulation Market Dynamics
1.5.1 Hematology and Coagulation Market Drivers
1.5.2 Hematology and Coagulation Market Restraints
1.5.3 Hematology and Coagulation Industry Trends
1.5.4 Hematology and Coagulation Industry Policy
2 Global Competitive Situation by Company
2.1 Global Hematology and Coagulation Revenue by Company (2018-2023)
2.2 Global Hematology and Coagulation Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Hematology and Coagulation Concentration Ratio
2.4 Global Hematology and Coagulation Mergers & Acquisitions, Expansion Plans
2.5 Global Hematology and Coagulation Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Hematology and Coagulation Revenue by Company (2018-2023)
3.2 China Hematology and Coagulation Hematology and Coagulation Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Hematology and Coagulation, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Hematology and Coagulation Industry Chain
4.2 Hematology and Coagulation Upstream Analysis
4.3 Hematology and Coagulation Midstream Analysis
4.4 Hematology and Coagulation Downstream Analysis
5 Sights by Type
5.1 Hematology and Coagulation Classification
5.1.1 Hematology
5.1.2 Coagulation
5.2 By Type, Global Hematology and Coagulation Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Hematology and Coagulation Revenue, 2018-2029
6 Sights by Application
6.1 Hematology and Coagulation Segment by Application
6.1.1 Children
6.1.2 Adult
6.2 By Application, Global Hematology and Coagulation Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Hematology and Coagulation Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Hematology and Coagulation Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Hematology and Coagulation Market Size, 2018-2029
7.3 North America
7.3.1 North America Hematology and Coagulation Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Hematology and Coagulation Market Size Market Share
7.4 Europe
7.4.1 Europe Hematology and Coagulation Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Hematology and Coagulation Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Hematology and Coagulation Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Hematology and Coagulation Market Size Market Share
7.6 South America
7.6.1 South America Hematology and Coagulation Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Hematology and Coagulation Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Hematology and Coagulation Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Hematology and Coagulation Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Hematology and Coagulation Market Size, 2018-2029
8.3.2 By Company, U.S. Hematology and Coagulation Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Hematology and Coagulation Market Size, 2018-2029
8.4.2 By Company, Europe Hematology and Coagulation Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Hematology and Coagulation Market Size, 2018-2029
8.5.2 By Company, China Hematology and Coagulation Revenue Market Share, 2018-2023
8.5.3 By Type, China Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Hematology and Coagulation Market Size, 2018-2029
8.6.2 By Company, Japan Hematology and Coagulation Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Hematology and Coagulation Market Size, 2018-2029
8.7.2 By Company, South Korea Hematology and Coagulation Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Hematology and Coagulation Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Hematology and Coagulation Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Hematology and Coagulation Market Size, 2018-2029
8.9.2 By Company, India Hematology and Coagulation Revenue Market Share, 2018-2023
8.9.3 By Type, India Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Hematology and Coagulation Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Hematology and Coagulation Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Hematology and Coagulation Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Abbott Diagnostics
9.1.1 Abbott Diagnostics Company Information, Head Office, Market Area and Industry Position
9.1.2 Abbott Diagnostics Company Profile and Main Business
9.1.3 Abbott Diagnostics Hematology and Coagulation Models, Specifications and Application
9.1.4 Abbott Diagnostics Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.1.5 Abbott Diagnostics Recent Developments
9.2 Beckman Coulter, Inc.
9.2.1 Beckman Coulter, Inc. Company Information, Head Office, Market Area and Industry Position
9.2.2 Beckman Coulter, Inc. Company Profile and Main Business
9.2.3 Beckman Coulter, Inc. Hematology and Coagulation Models, Specifications and Application
9.2.4 Beckman Coulter, Inc. Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.2.5 Beckman Coulter, Inc. Recent Developments
9.3 CellaVision AB
9.3.1 CellaVision AB Company Information, Head Office, Market Area and Industry Position
9.3.2 CellaVision AB Company Profile and Main Business
9.3.3 CellaVision AB Hematology and Coagulation Models, Specifications and Application
9.3.4 CellaVision AB Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.3.5 CellaVision AB Recent Developments
9.4 Diagnostica Stago, S.A.S.
9.4.1 Diagnostica Stago, S.A.S. Company Information, Head Office, Market Area and Industry Position
9.4.2 Diagnostica Stago, S.A.S. Company Profile and Main Business
9.4.3 Diagnostica Stago, S.A.S. Hematology and Coagulation Models, Specifications and Application
9.4.4 Diagnostica Stago, S.A.S. Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.4.5 Diagnostica Stago, S.A.S. Recent Developments
9.5 DIAGON Kft. Hungary
9.5.1 DIAGON Kft. Hungary Company Information, Head Office, Market Area and Industry Position
9.5.2 DIAGON Kft. Hungary Company Profile and Main Business
9.5.3 DIAGON Kft. Hungary Hematology and Coagulation Models, Specifications and Application
9.5.4 DIAGON Kft. Hungary Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.5.5 DIAGON Kft. Hungary Recent Developments
9.6 HemoCue
9.6.1 HemoCue Company Information, Head Office, Market Area and Industry Position
9.6.2 HemoCue Company Profile and Main Business
9.6.3 HemoCue Hematology and Coagulation Models, Specifications and Application
9.6.4 HemoCue Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.6.5 HemoCue Recent Developments
9.7 Horiba Medical
9.7.1 Horiba Medical Company Information, Head Office, Market Area and Industry Position
9.7.2 Horiba Medical Company Profile and Main Business
9.7.3 Horiba Medical Hematology and Coagulation Models, Specifications and Application
9.7.4 Horiba Medical Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.7.5 Horiba Medical Recent Developments
9.8 Medica Corporation
9.8.1 Medica Corporation Company Information, Head Office, Market Area and Industry Position
9.8.2 Medica Corporation Company Profile and Main Business
9.8.3 Medica Corporation Hematology and Coagulation Models, Specifications and Application
9.8.4 Medica Corporation Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.8.5 Medica Corporation Recent Developments
9.9 Microvisk Technologies
9.9.1 Microvisk Technologies Company Information, Head Office, Market Area and Industry Position
9.9.2 Microvisk Technologies Company Profile and Main Business
9.9.3 Microvisk Technologies Hematology and Coagulation Models, Specifications and Application
9.9.4 Microvisk Technologies Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.9.5 Microvisk Technologies Recent Developments
9.10 Mindray
9.10.1 Mindray Company Information, Head Office, Market Area and Industry Position
9.10.2 Mindray Company Profile and Main Business
9.10.3 Mindray Hematology and Coagulation Models, Specifications and Application
9.10.4 Mindray Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.10.5 Mindray Recent Developments
9.11 Roche Diagnostics
9.11.1 Roche Diagnostics Company Information, Head Office, Market Area and Industry Position
9.11.2 Roche Diagnostics Company Profile and Main Business
9.11.3 Roche Diagnostics Hematology and Coagulation Models, Specifications and Application
9.11.4 Roche Diagnostics Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.11.5 Roche Diagnostics Recent Developments
9.12 Siemens Healthineers
9.12.1 Siemens Healthineers Company Information, Head Office, Market Area and Industry Position
9.12.2 Siemens Healthineers Company Profile and Main Business
9.12.3 Siemens Healthineers Hematology and Coagulation Models, Specifications and Application
9.12.4 Siemens Healthineers Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.12.5 Siemens Healthineers Recent Developments
9.13 Sysmex Corporation
9.13.1 Sysmex Corporation Company Information, Head Office, Market Area and Industry Position
9.13.2 Sysmex Corporation Company Profile and Main Business
9.13.3 Sysmex Corporation Hematology and Coagulation Models, Specifications and Application
9.13.4 Sysmex Corporation Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.13.5 Sysmex Corporation Recent Developments
9.14 Werfen (Instrumentation Laboratory, Accriva Diagnostics)
9.14.1 Werfen (Instrumentation Laboratory, Accriva Diagnostics) Company Information, Head Office, Market Area and Industry Position
9.14.2 Werfen (Instrumentation Laboratory, Accriva Diagnostics) Company Profile and Main Business
9.14.3 Werfen (Instrumentation Laboratory, Accriva Diagnostics) Hematology and Coagulation Models, Specifications and Application
9.14.4 Werfen (Instrumentation Laboratory, Accriva Diagnostics) Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.14.5 Werfen (Instrumentation Laboratory, Accriva Diagnostics) Recent Developments
9.15 West Medica
9.15.1 West Medica Company Information, Head Office, Market Area and Industry Position
9.15.2 West Medica Company Profile and Main Business
9.15.3 West Medica Hematology and Coagulation Models, Specifications and Application
9.15.4 West Medica Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.15.5 West Medica Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|